Lymphangioma
Lymphangioma bụ arụrụ arụ nke sistemu lymphatic nke nwere ọnya nke bụ cysts nwere mgbidi dị mkpa. Ihe nhụsianya ndị a nwere ike ime n'afọ ọ bụla ma nwee ike ịgụnye akụkụ ọ bụla nke ahụ, ma 90% na-eme na ụmụaka na-erubeghị afọ 2 ma na-agụnye isi na olu. Lymphangiomas na-achọpụtakarị tupu a mụọ nwa site na iji ultrasonography nke nwa ebu n'afọ. Enwere ike nweta lymphangiomas site na trauma, mbufụt, ma ọ bụ mgbochi lymphatic. Ebe ọ bụ na ha enweghị ohere ịghọ ndị na-adịghị mma, a na-agwọkarị lymphangiomas maka ihe ịchọ mma naanị.
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
References
A na-akpọkwa Lymphangioma dị ka malformation lymphatic (LM) . Ọ bụ ọrịa vaskụla nke dị site n'ọmụmụ. Ihe e ji mara ya bụ mmụba na-adịghị mma nke anụ ahụ lymphatic tupu na mgbe amuchara nwa. Lymphangioma na-emetụta ihe dịka 1 n'ime 2000 ruo 4000 mmadụ, na-enweghị nnukwu ọdịiche dị n'etiti okike ma ọ bụ agbụrụ. Ọtụtụ ikpe (80-90%) ka a na-achọpụta tupu ha eruo afọ abụọ. Mgbaàmà na-adịgasị iche iche, site na ọzịza mpaghara ruo n'ọgba aghara dị ukwuu na ọwa lymphatic, mgbe ụfọdụ na-ebute ọzịza siri ike nke a maara dị ka elephantiasis. Dịka ọmụmaatụ, lymphangioma n'olu na ihu nwere ike ime ka ọzịza ihu, na n'ọnọdụ siri ike, nhụsianya. Mgbe ọ na-emetụta ire, ọ nwere ike ibute oke agba na ezé na-ezighi ezi. N'ọnụ na olu, ọ nwere ike ịkpata nsogbu iku ume na ihe mberede na-eyi ndụ egwu. N'anya, ọ nwere ike ime ka ọhụhụhụhụhụhụhụhụhụhụhụhụhụta-ọhụ-ọhụ-ọgụọgụọgụọgụ-dụ-mma,-ọkpu-eze-ikwa-a; Ntinye aka nwere ike ime ka ọzịza na uto na-adịghị mma nke anụ ahụ na ọkpụkpụ. Ụbụrụ a na-etokarị nwayọọ nwayọọ, ma ọrịa, mgbanwe mgbanwe hormonal, ma ọ bụ mmerụ ahụ nwere ike ime ka ọganihu ngwa ngwa, na-ebute ihe ize ndụ ndị na-eyi ndụ egwu nke chọrọ ọgwụgwọ ngwa ngwa.
Lymphangioma (lymphatic malformation, LM), a congenital vascular disease, is a low-flow vascular abnormality in lymphatic diseases that is characterized by excessive growth of lymphatic tissue during prenatal and postpartum development. The incidence rate of LM is ~1:2000–4000, with no variation between genders and races. Most patients (80–90%) are diagnosed before the age of two. The clinical manifestations of lymphangioma are quite different among patients, varying from local swelling leading to superficial mass to a large area of diffuse infiltrating lymphatic channel abnormalities resulting in elephantiasis. Cervicofacial LM can cause facial elephantiasis, and in some severe cases, it can lead to serious disfigurement of the face. Tongue LM can lead to mandibular overgrowth and occlusal asymmetry, and oral and cervical LM can cause obstructive acute respiratory distress and life-threatening situations. Orbital LM may lead to decreased vision, decreased extraocular muscle movement, ptosis and exophthalmos. LM of the extremities can trigger swelling or gigantism, accompanied by overgrowth of soft tissue and bones. LM usually grows slowly and steadily, but under certain conditions, such as infection, hormonal changes or trauma, it can grow explosively and become a life-threatening disease requiring immediate treatment.
Lymphangioma (lymphatic malformation, LM), a congenital vascular disease, is a low-flow vascular abnormality in lymphatic diseases that is characterized by excessive growth of lymphatic tissue during prenatal and postpartum development. The incidence rate of LM is ~1:2000–4000, with no variation between genders and races. Most patients (80–90%) are diagnosed before the age of two. The clinical manifestations of lymphangioma are quite different among patients, varying from local swelling leading to superficial mass to a large area of diffuse infiltrating lymphatic channel abnormalities resulting in elephantiasis. Cervicofacial LM can cause facial elephantiasis, and in some severe cases, it can lead to serious disfigurement of the face. Tongue LM can lead to mandibular overgrowth and occlusal asymmetry, and oral and cervical LM can cause obstructive acute respiratory distress and life-threatening situations. Orbital LM may lead to decreased vision, decreased extraocular muscle movement, ptosis and exophthalmos. LM of the extremities can trigger swelling or gigantism, accompanied by overgrowth of soft tissue and bones. LM usually grows slowly and steadily, but under certain conditions, such as infection, hormonal changes or trauma, it can grow explosively and become a life-threatening disease requiring immediate treatment.
N'ime ọmụmụ ihe a na-atụgharị azụ, anyị nyochara ụmụaka 24 nwere lymphangioma ma gwọọ ya na injections nke ngwọta bleomycin site na January 1999 ruo December 2004. Ọtụtụ n'ime ọnyá ahụ (63%) gabigara, 21% nwetara nzaghachi dị mma, na 16% azaghị nke ọma. Ndị ọrịa abụọ nwere etuto ahụ lọta ka emechara, mmadụ abụọ ndị ọzọ nwetara ọzịza ebe ha nwetara ntụtụ ahụ. N'ụzọ dị mma, anyị ahụghị nnukwu nsogbu ọzọ ma ọ bụ mmetụta ndị ọzọ.
This is a retrospective study of 24 children diagnosed with lymphangioma and treated with intralesional injection of bleomycin aqueous solution from January 1999 to December 2004. Complete resolution was seen in 63% (15/24) of lesions, 21% (5/24) had good response and 16% (4/24) had poor response. The tumour recurred in 2 patients. Two other patients had abscess formation at the site of injection. No other serious complications or side effects were observed.
This is a retrospective study of 24 children diagnosed with lymphangioma and treated with intralesional injection of bleomycin aqueous solution from January 1999 to December 2004. Complete resolution was seen in 63% (15/24) of lesions, 21% (5/24) had good response and 16% (4/24) had poor response. The tumour recurred in 2 patients. Two other patients had abscess formation at the site of injection. No other serious complications or side effects were observed.
Ụdị isi nke lymphangioma bụ ndị a - lymphangioma circumscriptum, cavernous lymphangioma, cystic hygroma, lymphangioendothelioma. Ndị a na-eme ihe dị ka 26% nke etuto vaskụla benign na ụmụaka mana ha anaghị adịkarị na ndị okenye. Lymphangioma circumscriptum , ụdị nke a na-emekarị, na-egosi eriri lymph na-esi na akpụkpọ ahụ pụta, na-akpụ vesicles doro anya nke jupụtara na mmiri dị ka frog spawn, yana ọzịza anụ ahụ. Ọ na-apụtakarị na mpaghara nwere nnukwu netwọkụ lymphatic dị ka akụkụ aka, ogwe, na ogwe aka. Otu nwanyị dị afọ 71 bịara n'ụlọọgwụ anyị nwere ọzịza ụkwụ na-adịgide adịgide, mgbaka pink n'akụkụ akụkụ akụkụ akụkụ ahụ ya, ọzịza, na mmiri mmiri na-agbapụta. Anyị na-eji usoro a na-akpọ bilateral major labiectomy, na-akwụsị na Colles' fascia larịị, na-echekwa clitoris na fourchette.
The predominant types of lymphangioma are lymphangioma circumscriptum (LC), cavernous lymphangioma, cystic hygroma, and lymphangioendothelioma. These entities account for approximately 26% of benign vascular tumors in children but are rarer in adults. LC is the most common form of cutaneous lymphangioma and is characterized by superficial lymphatic ducts protruding through the epidermis. This condition results in clusters of clear fluid-filled vesicles resembling frog spawn and associated tissue edema. It is usually found on the proximal extremity, trunk, and axilla, which has an abundant lymphatic system. A 71-year-old female presented to our outpatient clinic with persistent edema of both lower limbs, clusters of pink labial papules, pruritus, and watery lymph oozing. We removed all the papules by performing bilateral major labiectomy down to the level of Colles' fascia, sparing the clitoris and fourchette.
The predominant types of lymphangioma are lymphangioma circumscriptum (LC), cavernous lymphangioma, cystic hygroma, and lymphangioendothelioma. These entities account for approximately 26% of benign vascular tumors in children but are rarer in adults. LC is the most common form of cutaneous lymphangioma and is characterized by superficial lymphatic ducts protruding through the epidermis. This condition results in clusters of clear fluid-filled vesicles resembling frog spawn and associated tissue edema. It is usually found on the proximal extremity, trunk, and axilla, which has an abundant lymphatic system. A 71-year-old female presented to our outpatient clinic with persistent edema of both lower limbs, clusters of pink labial papules, pruritus, and watery lymph oozing. We removed all the papules by performing bilateral major labiectomy down to the level of Colles' fascia, sparing the clitoris and fourchette.
